These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
277 related items for PubMed ID: 20508203
21. Nicotine potentiates proatherogenic effects of oxLDL by stimulating and upregulating macrophage CD36 signaling. Zhou MS, Chadipiralla K, Mendez AJ, Jaimes EA, Silverstein RL, Webster K, Raij L. Am J Physiol Heart Circ Physiol; 2013 Aug 15; 305(4):H563-74. PubMed ID: 23748423 [Abstract] [Full Text] [Related]
22. Enhancing PPARγ by HDAC inhibition reduces foam cell formation and atherosclerosis in ApoE deficient mice. Gao Q, Wei A, Chen F, Chen X, Ding W, Ding Z, Wu Z, Du R, Cao W. Pharmacol Res; 2020 Oct 15; 160():105059. PubMed ID: 32621955 [Abstract] [Full Text] [Related]
23. Inhibition of Macrophage CD36 Expression and Cellular Oxidized Low Density Lipoprotein (oxLDL) Accumulation by Tamoxifen: A PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR (PPAR)γ-DEPENDENT MECHANISM. Yu M, Jiang M, Chen Y, Zhang S, Zhang W, Yang X, Li X, Li Y, Duan S, Han J, Duan Y. J Biol Chem; 2016 Aug 12; 291(33):16977-89. PubMed ID: 27358406 [Abstract] [Full Text] [Related]
24. FABP4 inhibition suppresses PPARγ activity and VLDL-induced foam cell formation in IL-4-polarized human macrophages. Boss M, Kemmerer M, Brüne B, Namgaladze D. Atherosclerosis; 2015 Jun 12; 240(2):424-30. PubMed ID: 25897794 [Abstract] [Full Text] [Related]
25. Pioglitazone-Incorporated Nanoparticles Prevent Plaque Destabilization and Rupture by Regulating Monocyte/Macrophage Differentiation in ApoE-/- Mice. Nakashiro S, Matoba T, Umezu R, Koga J, Tokutome M, Katsuki S, Nakano K, Sunagawa K, Egashira K. Arterioscler Thromb Vasc Biol; 2016 Mar 12; 36(3):491-500. PubMed ID: 26821947 [Abstract] [Full Text] [Related]
26. Corosolic acid ameliorates atherosclerosis in apolipoprotein E-deficient mice by regulating the nuclear factor-κB signaling pathway and inhibiting monocyte chemoattractant protein-1 expression. Chen H, Yang J, Zhang Q, Chen LH, Wang Q. Circ J; 2012 Mar 12; 76(4):995-1003. PubMed ID: 22293444 [Abstract] [Full Text] [Related]
27. Effect of beta-3 adrenoceptor stimulation on the levels of ApoA-I, PPARα, and PPARγ in apolipoprotein E-deficient mice. Shi ST, Li YF, Guo YQ, Wang ZH. J Cardiovasc Pharmacol; 2014 Nov 12; 64(5):407-11. PubMed ID: 24979391 [Abstract] [Full Text] [Related]
28. GM-CSF deficiency reduces macrophage PPAR-gamma expression and aggravates atherosclerosis in ApoE-deficient mice. Ditiatkovski M, Toh BH, Bobik A. Arterioscler Thromb Vasc Biol; 2006 Oct 12; 26(10):2337-44. PubMed ID: 16873730 [Abstract] [Full Text] [Related]
29. Peptidoglycan induced expression of peroxisome proliferator-activated receptor γ in mouse peritoneal macrophages: role of ERK and JNK MAP kinases. Bhatt KH, Sodhi A, Chakraborty R. Cytokine; 2012 Dec 12; 60(3):778-86. PubMed ID: 22925536 [Abstract] [Full Text] [Related]
30. Hawthorn (Crataegus pinnatifida Bunge) leave flavonoids attenuate atherosclerosis development in apoE knock-out mice. Dong P, Pan L, Zhang X, Zhang W, Wang X, Jiang M, Chen Y, Duan Y, Wu H, Xu Y, Zhang P, Zhu Y. J Ethnopharmacol; 2017 Feb 23; 198():479-488. PubMed ID: 28119096 [Abstract] [Full Text] [Related]
31. Tanshinone IIA attenuates atherosclerosis in ApoE(-/-) mice through down-regulation of scavenger receptor expression. Tang FT, Cao Y, Wang TQ, Wang LJ, Guo J, Zhou XS, Xu SW, Liu WH, Liu PQ, Huang HQ. Eur J Pharmacol; 2011 Jan 10; 650(1):275-84. PubMed ID: 20854809 [Abstract] [Full Text] [Related]
32. Anti-atherosclerotic potential of baicalin mediated by promoting cholesterol efflux from macrophages via the PPARγ-LXRα-ABCA1/ABCG1 pathway. He XW, Yu D, Li WL, Zheng Z, Lv CL, Li C, Liu P, Xu CQ, Hu XF, Jin XP. Biomed Pharmacother; 2016 Oct 10; 83():257-264. PubMed ID: 27389392 [Abstract] [Full Text] [Related]
33. High-density lipoproteins suppress chemokines and chemokine receptors in vitro and in vivo. Bursill CA, Castro ML, Beattie DT, Nakhla S, van der Vorst E, Heather AK, Barter PJ, Rye KA. Arterioscler Thromb Vasc Biol; 2010 Sep 10; 30(9):1773-8. PubMed ID: 20702809 [Abstract] [Full Text] [Related]
34. Insulin-Like Growth Factor-1 Receptor Deficiency in Macrophages Accelerates Atherosclerosis and Induces an Unstable Plaque Phenotype in Apolipoprotein E-Deficient Mice. Higashi Y, Sukhanov S, Shai SY, Danchuk S, Tang R, Snarski P, Li Z, Lobelle-Rich P, Wang M, Wang D, Yu H, Korthuis R, Delafontaine P. Circulation; 2016 Jun 07; 133(23):2263-78. PubMed ID: 27154724 [Abstract] [Full Text] [Related]
35. Nifedipine, a calcium channel blocker, inhibits advanced glycation end product (AGE)-elicited mesangial cell damage by suppressing AGE receptor (RAGE) expression via peroxisome proliferator-activated receptor-gamma activation. Matsui T, Yamagishi S, Takeuchi M, Ueda S, Fukami K, Okuda S. Biochem Biophys Res Commun; 2009 Jul 24; 385(2):269-72. PubMed ID: 19460355 [Abstract] [Full Text] [Related]
36. Activation of TRPV1 reduces vascular lipid accumulation and attenuates atherosclerosis. Ma L, Zhong J, Zhao Z, Luo Z, Ma S, Sun J, He H, Zhu T, Liu D, Zhu Z, Tepel M. Cardiovasc Res; 2011 Dec 01; 92(3):504-13. PubMed ID: 21908651 [Abstract] [Full Text] [Related]
37. Microarray analysis of gene expression in mouse aorta reveals role of the calcium signaling pathway in control of atherosclerosis susceptibility. Yuan Z, Miyoshi T, Bao Y, Sheehan JP, Matsumoto AH, Shi W. Am J Physiol Heart Circ Physiol; 2009 May 01; 296(5):H1336-43. PubMed ID: 19304945 [Abstract] [Full Text] [Related]
38. Effect of a new PPAR-gamma agonist, lobeglitazone, on neointimal formation after balloon injury in rats and the development of atherosclerosis. Lim S, Lee KS, Lee JE, Park HS, Kim KM, Moon JH, Choi SH, Park KS, Kim YB, Jang HC. Atherosclerosis; 2015 Nov 01; 243(1):107-19. PubMed ID: 26363808 [Abstract] [Full Text] [Related]
39. Propofol up-regulates expression of ABCA1, ABCG1, and SR-B1 through the PPARγ/LXRα signaling pathway in THP-1 macrophage-derived foam cells. Ma X, Li SF, Qin ZS, Ye J, Zhao ZL, Fang HH, Yao ZW, Gu MN, Hu YW. Cardiovasc Pathol; 2015 Nov 01; 24(4):230-5. PubMed ID: 25600616 [Abstract] [Full Text] [Related]
40. Peroxisome proliferator-activated receptor-gamma1 gene therapy attenuates atherosclerosis and stabilizes plaques in apolipoprotein E-deficient mice. Hu Q, Zhang XJ, Zhang C, Zhao YX, He H, Liu CX, Feng JB, Jiang H, Yang FL, Zhang CX, Zhang Y. Hum Gene Ther; 2008 Mar 01; 19(3):287-299. PubMed ID: 18302511 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]